Sign Out
Pregnancy: The safe use of the product during pregnancy has not been established. Therefore, the product should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. The inhibitory effect of the product on uterine contraction should be taken into account.
Labor and Delivery: Since beta2-agonists may interfere with uterine contraction, the product should be used in labor only if the potential benefit justifies the potential risk.
Lactation: Ipratropium bromide and Salbutamol may be secreted in breast milk. Therefore, do not administer to breastfeeding women unless, in the opinion of a physician, the potential benefits of the product justify the possible risk.
Continue with Google